ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryPrattelnSanthera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

Santhera Pharmaceuticals (Schweiz) AG develops and commercializes medicines for patients with rare and other diseases that have high unmet medical needs. The company focuses on developing treatments for neuromuscular disorders, such as Duchenne muscular dystrophy.

AI-generated
Offering
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Santhera Pharmaceuticals (Schweiz) AG

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Medicines for rare neuromuscular and pulmonary diseases
Development of treatments for rare diseases, in particular neuromuscular and pulmonary diseases with unmet medical need.
AGAMREE® (vamorolone)
AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy; described on the website with approval status, product information and ordering instructions for pharmacies.
Scientific publications and clinical information
Scientific publications, clinical studies and medical information on AGAMREE® and the development programme with vamorolone.
Career positions
Open positions and career information for employees in an international environment of medical science.
Trust & reputation

ranQ Trust Score of Santhera Pharmaceuticals (Schweiz) AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 100% · As of October 2026

Santhera Pharmaceuticals (Schweiz) AG scores 54.8 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.69.624%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.35.310%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.35.08%
Santhera Pharmaceuticals (Schweiz) AG scores 92.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Santhera Pharmaceuticals (Schweiz) AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Santhera Pharmaceuticals (Schweiz) AG scores 60.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.20.04%
Qualifications+0.00

Santhera Pharmaceuticals (Schweiz) AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». The rating draws, among other things, on 4.7 out of 5 stars from 3 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.7
of 5

Aggregated from 3 reviews across all connected sources

Sources
GGoogle4.73
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

January 8, 2026Media
Aktie von Santhera vollzieht Kurssprung nach Lizenzvereinbarung für Medikament Agamree
cash.ch

Knowledge

No knowledge articles yet

Once Santhera Pharmaceuticals (Schweiz) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Santhera Pharmaceuticals (Schweiz) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Santhera Pharmaceuticals (Schweiz) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Santhera Pharmaceuticals (Schweiz) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hohenrainstrasse 24
4133 Pratteln

At a glance

Legal form
Corporation
UID
CHE-112.001.828
Founded
2004 · 22 years
Last commercial register change
September 4, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GP
    Gebro Pharma AG
    Liestal
    AH
    Accord Healthcare AG
    Bottmingen
    CG
    Cederberg GmbH
    Binningen
    NS
    Neurocrine Switzerland GmbH
    Allschwil
    HA
    Herbonis Animal Health GmbH
    Augst Bl
    AG
    Allpack Group AG
    Reinach Bl
    MA
    Medius AG
    Muttenz
    AP
    Actelion Pharmaceuticals Ltd
    Allschwil